Tech Company Financing Transactions
Genetesis Funding Round
Genetesis, operating out of Mason, secured $17.5 million from Mithril Capital Management, Cercano Management and CincyTech.
Transaction Overview
Company Name
Announced On
10/7/2022
Transaction Type
Venture Equity
Amount
$17,500,000
Round
Series C
Investors
Mithril Capital Management (Lead Investor)
CincyTech (John Rice)
Proceeds Purpose
The company intends to use the funds to obtain FDA De Novo approval, launch a new series of clinical trials, and commercialize and launch its biomagnetic systems globally across a variety of care settings.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5412 Courseview Dr. 150
Mason, OH 45040
USA
Mason, OH 45040
USA
Phone
Website
Email Address
Overview
Genetesis was founded in Mason, Ohio in 2013 and now employs a team of ten. Genetesis will use this funding to scale its engineering, launch additional clinical studies and seek regulatory clearance from the FDA.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peeyush Shrivastava
Chief Financial Officer
Chandan Srivastava
Chief Medical Officer
Alisa Niksch
Chief Operating Officer
Vineet Erasala
Chief Technical Officer
Emmanuel Setegn
Vice President
Jeffrey Bush
Vice President
Rick Karr
VP - Regulatory Affairs
Robert Sokolowski
Browse more venture capital transactions:
Prev: 10/7/2022: Tyles.io venture capital transaction
Next: 10/7/2022: Gamurs venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. VC investment data records on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs